sur Biotricity, Inc. (NASDAQ:BTCY)
Biotricity Launches Cardiac Monitoring Pilot Program Across 60 Sites
Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service company in the remote cardiac monitoring sector, announced a pilot program with a prominent hospital group. This initiative spans 60 sites across multiple states, aiming to enhance cardiac care.
The program will utilize Biotricity's unique three-channel connected cardiac monitoring solution. This technology aims to provide superior diagnostics, reduce patient risk, and enhance workflow efficiency, leading to improved clinical outcomes and lower healthcare costs. It also promises to increase revenue for providers significantly.
Founder and CEO Dr. Waqaas Al-Siddiq stated that the pilot program would accelerate the adoption of their products. This opportunity allows Biotricity to demonstrate its technology's effectiveness in diverse healthcare settings.
Through collaboration with healthcare professionals, the program aims to enhance patient interaction protocols and optimize data collection processes. This initiative builds on previous programs to showcase the transformative potential of Biotricity's technology in improving cardiac care.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Biotricity, Inc.